IXAZOMIB CITRATE 1,3,2-DIOXABORINANE
UNII E8R04MBQ04
Substance Identification & Data
This profile provides standardized clinical and technical data for Ixazomib Citrate 1,3,2-dioxaborinane, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E8R04MBQ04.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1201902-80-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H23BCl2N2O9 YTXSYWAKVMZICI-PVCZSOGJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ixazomib Citrate 1,3,2-dioxaborinane. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.